AMPHOTERICIN-B AND ITS DELIVERY BY LIPOSOMAL AND LIPID FORMULATIONS

被引:65
作者
GATES, C [1 ]
PINNEY, RJ [1 ]
机构
[1] UNIV LONDON,SCH PHARM,DEPT PHARMACEUT,MICROBIOL SECT,BRUNSWICK SQ,LONDON WC1N 1AX,ENGLAND
关键词
D O I
10.1111/j.1365-2710.1993.tb00605.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years, new formulations of the original amphotericin B preparation (Fungizone) have been devised in order to overcome toxicity problems that frequently occur. These preparations represent an improved method of drug delivery, with an increased therapeutic index and a decrease in toxicity to mammalian cell membranes. The new formulations have different physico-chemical characteristics and differ in pharmacokinetic parameters. Their effects must be compared with conventional amphotericin B to ascertain potential roles in future antifungal therapy.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 59 条